Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Polymers: Defining Molecular Weight01:01

Polymers: Defining Molecular Weight

3.8K
Unlike small molecules with definite molecular weights, polymers are a mixture of individual polymer chains of varying lengths, each with a unique molecular weight.  So, the molecular weight of a polymer is expressed as an average value based on the average size of the polymer chains. The two most common forms of averages used for polymers are the number average molecular weight and weight average molecular weight.
The number average molecular weight (Mn) is the summation of the number...
3.8K
Relative Risk01:12

Relative Risk

2.0K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Defining Psychology01:24

Defining Psychology

7.6K
Psychology is the scientific discipline dedicated to understanding both observable behavior and the internal mental processes underlying such behavior. It aims to comprehend human nature and apply this understanding to solve practical problems, enhance well-being, and improve societal outcomes. An example of psychology's application is the study of prosocial behavior, such as why and under what conditions individuals might help strangers in need. This process involves describing observed...
7.6K
Defining Social Psychology01:09

Defining Social Psychology

387
Social psychology investigates how the presence and actions of others influence individual behavior, cognition, and emotion. Examining the social environment's impact provides a scientific framework for understanding how individuals perceive others and are, in turn, influenced by them. This field seeks to uncover the underlying principles guiding social interactions, exploring phenomena such as conformity, obedience, and prosocial behavior.Core Themes in Social PsychologyOne central focus of...
387
Molecular Models02:00

Molecular Models

43.6K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Response to the Letter to the Editor: Population-informed Assessment of Clonality in Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancers.

NPJ precision oncology·2026
Same author

Seminal vesicle injury during radical prostatectomy does not affect the oncological outcome of prostate cancer patients.

Prostate international·2026
Same author

Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.

NPJ precision oncology·2026
Same author

Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.

Seminars in cancer biology·2026

Related Experiment Video

Updated: Jan 24, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.6K

Defining molecular risk in ALK+ NSCLC.

Petros Christopoulos1,2, Jan Budczies3, Martina Kirchner3

  • 1Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Baden Württemberg, Heidelberg, Germany.

Oncotarget
|May 30, 2019
PubMed
Summary

Anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) has a unique, genetically simple landscape. Specific mutations like EML4-ALK and TP53 impact prognosis and treatment response in ALK+ NSCLC.

Keywords:
ALK+ non-small cell lung cancerEML4-ALK fusion variantTP53 mutationoverall survivaltreatment resistance

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.6K
Molecular Evolution of the Tre Recombinase
12:02

Molecular Evolution of the Tre Recombinase

Published on: May 29, 2008

10.1K

Related Experiment Videos

Last Updated: Jan 24, 2026

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.6K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.6K
Molecular Evolution of the Tre Recombinase
12:02

Molecular Evolution of the Tre Recombinase

Published on: May 29, 2008

10.1K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) exhibits a favorable prognosis, exceeding 5-year median survival.
  • The genetic landscape of ALK+ NSCLC is characterized by low tumor mutational burden and infrequent TP53 mutations, differentiating it from other NSCLC subtypes.
  • This genetic simplicity facilitates the study of individual molecular features and their impact on disease course.

Purpose of the Study:

  • To identify key molecular determinants associated with adverse outcomes in ALK-positive NSCLC.
  • To understand the role of EML4-ALK fusion variant 3 and TP53 mutations in disease progression and survival.
  • To explore the significance of secondary TP53 mutations and ALK resistance mutations in guiding therapeutic strategies.

Main Methods:

  • Analysis of genetic profiles in ALK-positive NSCLC patients.
  • Correlation of specific mutations (EML4-ALK variant 3, TP53) with clinical outcomes, including progression-free survival and overall survival.
  • Investigation of secondary mutations arising during disease progression.

Main Results:

  • EML4-ALK fusion variant 3 (E6;A20) and TP53 mutations are identified as major molecular determinants of adverse outcomes in approximately 30-40% and 20-25% of cases, respectively.
  • These mutations are independently associated with more aggressive disease, shorter progression-free survival under ALK inhibitor treatment, and worse overall survival.
  • Secondary TP53 mutations detected at progression define a subset with poor outcomes, and ALK resistance mutations guide subsequent treatment choices.

Conclusions:

  • The genetic landscape of ALK-positive NSCLC, particularly the presence of EML4-ALK variant 3 and TP53 mutations, significantly influences clinical outcomes.
  • Understanding these molecular drivers is crucial for predicting disease behavior and personalizing treatment strategies.
  • Further identification of molecular risk factors will refine patient management and preclinical modeling for ALK-positive NSCLC.